LakeShore Biopharma Co., Ltd.
LakeShore Biopharma Co., Ltd.
Your view on LSBPW
Overview
What the company does, where it operates, and who runs it.
About LakeShore Biopharma Co., Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Wang Xu
- Headquarters
- Building No. 2, Beijing, CN
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Wang Xu
- Headquarters
- Building No. 2, Beijing, CN
LakeShore Biopharma Co., Ltd. is a biopharmaceutical enterprise dedicated to the discovery, development, manufacturing, and commercialization of vaccines and therapeutic biologics. These solutions are primarily aimed at combating infectious diseases and various forms of cancer. Central to its operations is the company's proprietary PIKA immunomodulating technology platform. Its product pipeline showcases significant developments, including the PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. LakeShore Biopharma maintains a global operational footprint, with activities spanning China, the United States, Singapore, the United Arab Emirates, and the Philippines. Established in 2002, the company is headquartered in Beijing, China. It formally adopted the name LakeShore Biopharma Co., Ltd. in May 2024, having previously operated as YS Biopharma Co., Ltd.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for LakeShore Biopharma Co., Ltd., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for LakeShore Biopharma Co., Ltd.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for LakeShore Biopharma Co., Ltd.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for LakeShore Biopharma Co., Ltd.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for LakeShore Biopharma Co., Ltd.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
LakeShore Biopharma Co., Ltd. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold LakeShore Biopharma Co., Ltd., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by LakeShore Biopharma Co., Ltd. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming LakeShore Biopharma Co., Ltd.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming LakeShore Biopharma Co., Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for LakeShore Biopharma Co., Ltd.. Press releases and market coverage, newest first.